Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Leon

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Clinical Trials (London, England)|November 26, 2009
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and designAndrew A Nierenberg, Louisa G Sylvia, Andrew C Leon, et al.
Schizophrenia Bulletin|August 26, 2006
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshopAlan S Bellack, Michael F Green, Judith A Cook, et al.
The American Journal of Psychiatry|January 5, 2013
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithiumAndrew A Nierenberg, Edward S Friedman, Charles L Bowden, et al.
Journal of Affective Disorders|September 8, 2014
The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorderLouisa G Sylvia, Dustin J Rabideau, Andrew A Nierenberg, et al.
Clinical Trials (London, England)|May 30, 2014
A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trialDustin J Rabideau, Andrew A Nierenberg, Louisa G Sylvia, et al.
Psychiatric Services (Washington, D.C.)|August 16, 2013
Use of treatment services in a comparative effectiveness study of bipolar disorderLouisa G Sylvia, Dan Iosifescu, Edward S Friedman, et al.
Clinical Trials (London, England)|November 15, 2011
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorderLouisa G Sylvia, Noreen A Reilly-Harrington, Andrew C Leon, et al.
Journal of Psychiatric Research|August 6, 2013
The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness researchNoreen A Reilly-Harrington, Louisa G Sylvia, Andrew C Leon, et al.
Journal of Affective Disorders|April 2, 2015
An exploratory study of responses to low-dose lithium in African Americans and HispanicsJodi Gonzalez Arnold, Stephanie Salcedo, Terrence A Ketter, et al.
Journal of Affective Disorders|November 13, 2010
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depressionDavid E Kemp, Stephen J Ganocy, Martin Brecher, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Clinical Trials (London, England)|November 26, 2009
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and designAndrew A Nierenberg, Louisa G Sylvia, Andrew C Leon, et al.
Schizophrenia Bulletin|August 26, 2006
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshopAlan S Bellack, Michael F Green, Judith A Cook, et al.
The American Journal of Psychiatry|January 5, 2013
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithiumAndrew A Nierenberg, Edward S Friedman, Charles L Bowden, et al.
Journal of Affective Disorders|September 8, 2014
The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorderLouisa G Sylvia, Dustin J Rabideau, Andrew A Nierenberg, et al.
Clinical Trials (London, England)|May 30, 2014
A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trialDustin J Rabideau, Andrew A Nierenberg, Louisa G Sylvia, et al.
Psychiatric Services (Washington, D.C.)|August 16, 2013
Use of treatment services in a comparative effectiveness study of bipolar disorderLouisa G Sylvia, Dan Iosifescu, Edward S Friedman, et al.
Clinical Trials (London, England)|November 15, 2011
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorderLouisa G Sylvia, Noreen A Reilly-Harrington, Andrew C Leon, et al.
Journal of Psychiatric Research|August 6, 2013
The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness researchNoreen A Reilly-Harrington, Louisa G Sylvia, Andrew C Leon, et al.
Journal of Affective Disorders|April 2, 2015
An exploratory study of responses to low-dose lithium in African Americans and HispanicsJodi Gonzalez Arnold, Stephanie Salcedo, Terrence A Ketter, et al.
Journal of Affective Disorders|November 13, 2010
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depressionDavid E Kemp, Stephen J Ganocy, Martin Brecher, et al.
Pageof 13